GlassScriptPhysician profile
Michelle Lunsford
NPI 1841353752
$6,765.83
in general payments reported to CMS, 2019-2025
32 companies · $438 in 2025
The $438 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $733 · 2022: $1,665 · 2023: $2,021 · 2024: $1,909 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,313 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,312.78 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,530.32 | 2021-2025 | |
| Amgen INC. | $1,029.58 | 2021-2025 | Enbrel, Otezla, Evenity |
| Pfizer INC. | $724.53 | 2021-2025 | |
| Janssen Biotech, INC. | $553.82 | 2021-2024 | Tremfya, Simponi, Remicade |
| Novartis Pharmaceuticals Corporation | $443.77 | 2021-2025 | |
| Lilly USA, LLC | $346.92 | 2021-2024 | Taltz |
| Astrazeneca Pharmaceuticals LP | $336.79 | 2021-2025 | Saphnelo |
| Ucb, INC. | $313.94 | 2021-2025 | Cimzia, Bimzelx |
| Mallinckrodt Hospital Products INC. | $205.37 | 2022-2025 | Acthar |
| Ani Pharmaceuticals, INC. | $188.73 | 2022-2024 | Purified Cortrophin Gel |
| Horizon Therapeutics Plc | $113.69 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $104.37 | 2021-2023 | Strensiq |
| Glaxosmithkline, LLC. | $103.44 | 2022-2024 | Benlysta |
| Sandoz INC. | $95.62 | 2023-2024 | Hyrimoz |
| Radius Health, INC. | $76.70 | 2024-2025 | Tymlos |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocon Biologics INC | $68.27 | 2023-2025 | Hulio, Yesintek |
| Aurinia Pharma U.S., INC. | $63.61 | 2022-2024 | Lupkynis |
| Hikma Pharmaceuticals USA | $61.02 | 2022 | |
| Zimmer Biomet Holdings, INC. | $59.89 | 2025 | Intellicart |
| Ultragenyx Pharmaceutical INC. | $43.05 | 2021-2024 | Crysvita |
| Kyowa Kirin, INC. | $38.00 | 2024 | Crysvita |
| Fresenius Kabi USA, LLC | $35.82 | 2024 | Idacio |
| Sobi, INC | $30.63 | 2023 | |
| Mylan Institutional INC. | $26.17 | 2023 | Hulio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.47 | 2021 | |
| Organon LLC | $22.72 | 2023 | Renflexis, Hadlima |
| Alvogen INC | $22.53 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $22.50 | 2024 | Orencia |
| Genentech USA, INC. | $22.44 | 2021 | |
| Octapharma USA, INC. | $21.36 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $19.59 | 2024 | Arcalyst |
| Cumberland Pharmaceuticals, INC. | $15.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Lunsford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.